Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Do Changes in Transplant Practice Influence Risk of Therapy-Related Myelodysplasia/ Acute Myeloid Leukemia after Autologous Hematopoietic Cell Transplantation (aHCT) for Non-Hodgkin Lymphoma (NHL)?

Can-Lan Sun, Jennifer Berano-Teh, Patrick Halliday, Lindsey Hageman, Maya Ramamurthy, Saro Armenian, Alicia Gonzales, Liezl Atencio, Liton Francisco, F. Lennie Wong, Auayporn Nademanee, MD, Robert W Chen, MD, Margaret O'Donnell, Joseph Rosenthal, Leslie L. Popplewell, MD, Shirong Wang, Stephen J. Forman, Ravi Bhatia, Smita Bhatia, PhD

Blood (2014) 124 (21): 430.

https://doi.org/10.1182/blood.V124.21.430.430

Published: 2014

Journal Articles

Genetic Susceptibility to Anthracycline-Related Congestive Heart Failure (CHF) in Survivors of Hematopoietic Cell Transplantation (HCT)

Saro H. Armenian, DO, MPH, Yan Ding, PhD, George Mills, III, Can-Lan Sun, PhD, Kalyanasundaram Venkatraman, MD, F. Lennie Wong, PhD, David Senitzer, PhD, Shirong Wang, MD, Stephen J. Forman, MD, Smita Bhatia, MD, MPH

Blood (2012) 120 (21): 589.

https://doi.org/10.1182/blood.V120.21.589.589

Published: 2012

Journal Articles

Altered Hematopoietic Cell Gene Expression Identifies Patients at Risk for Development of Therapy-Related Leukemia (t-MDS/AML)

Liang Li, Min Li, Can-Lan Sun, Liton Francisco, Melanie Sabado, Tinisha McDonald, Janelle Gyorffy, Karen Chang, Shirong Wang, Wenhong Fan, Jiangning Li, Lue Ping Zhao, Jerald Radich, Stephen J. Forman, Smita Bhatia, Ravi Bhatia

Blood (2010) 116 (21): 234.

https://doi.org/10.1182/blood.V116.21.234.234

Published: 2010

Journal Articles

Gene Expression Changes in CD34+ Cells Precede Development of Therapy-Related Leukemia (t-MDS/AML) After Autologous Hematopoietic Cell Transplantation (aHCT) for Hodgkin (HL) or Non-Hodgkin Lymphoma (NHL).

Liang Li, Min Li, Can-Lan Sun, Melanie D. Sabado, Liton Francisco, Tinisha McDonald, Karen L. Chang, Shirong Wang, Jerald Radich, Lue Ping Zhao, Stephen J. Forman, Smita Bhatia, Ravi Bhatia

Blood (2009) 114 (22): 677.

https://doi.org/10.1182/blood.V114.22.677.677

Published: 2009

Journal Articles

Improved Outcome After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RI-HCT) for Myelodysplastic Syndrome (MDS) Using Tacrolimus/Sirolimus-Based Gvhd Prophylaxis.

Ryotaro Nakamura, MD, Joycelynne Palmer, Pablo Parker, Anthony Stein, Tracey Stiller, Vinod Pullarkat, David S. Snyder, MD, Ji-Lian Cai, MD, PhD, Shirong Wang, MD, MPH, David Senitzer, PhD, Karen L. Chang, Ravi Bhatia, Stephen J Forman, MD, Margaret O'Donnell, MD

Blood (2009) 114 (22): 2771.

https://doi.org/10.1182/blood.V114.22.2771.2771

Published: 2009

Journal Articles

Peripheral Hematopoietic Stem Cell Mobilization and Collection Efficacy Is Not an Independent Prognostic Factor for Autologous Stem Cell Transplantation.

Shirong Wang, MD, Auayporn P. Nademanee, MD, Dajun Qian, PhD, Andrew Dagis, PhD, Hyun-Soon Park, RN, Joy Fridey, MD, Eileen Patricia Smith, MD, David S. Snyder, MD, Ravi Bhatia, MD, Peter M. Falk, MD, Candace Kay, MT, Young Sun Kim, MD, Neil Martin Kogut, MD, Joycelynne Palmer, PhD, Joseph Rosenthal, MD, George Somlo, MD, Anthony Selwyn Stein, MD, Shan Yuan, MD, Stephen J. Forman, MD

Blood (2006) 108 (11): 5434.

https://doi.org/10.1182/blood.V108.11.5434.5434

Published: 2006

Journal Articles

Evaluating the Clinical Efficacy of Increased Granulocyte Colony-Stimulation Factor (GCSF) in Patients Who Fail a Standard Dose Regimen during Peripheral Blood Stem Cell Collection.

Blood (2004) 104 (11): 2926.

https://doi.org/10.1182/blood.V104.11.2926.2926

Published: 2004

Journal Articles

Feasibility and Efficacy of Mobilization of BCR/ABL- PBSC in CML Patients Receiving Imatinib.

Ravi Bhatia, MD, Helen Xu, BS, David Snyder, MD, Tinisha McDonald, Marilyn Slovak, PhD, Su Chu, MD, Allen Lin, BS, Leslie Popplewell, MD, Neil Kogut, MD, Shirong Wang, MD, Stephen Forman, MD

Blood (2004) 104 (11): 2858.

https://doi.org/10.1182/blood.V104.11.2858.2858

Published: 2004

NARROW

Do Changes in Transplant Practice Influence Risk of Therapy-Related Myelodysplasia/ Acute Myeloid Leukemia after Autologous Hematopoietic Cell Transplantation (aHCT) for Non-Hodgkin Lymphoma (NHL)?

Genetic Susceptibility to Anthracycline-Related Congestive Heart Failure (CHF) in Survivors of Hematopoietic Cell Transplantation (HCT)

Altered Hematopoietic Cell Gene Expression Identifies Patients at Risk for Development of Therapy-Related Leukemia (t-MDS/AML)

Gene Expression Changes in CD34+ Cells Precede Development of Therapy-Related Leukemia (t-MDS/AML) After Autologous Hematopoietic Cell Transplantation (aHCT) for Hodgkin (HL) or Non-Hodgkin Lymphoma (NHL).

Improved Outcome After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation (RI-HCT) for Myelodysplastic Syndrome (MDS) Using Tacrolimus/Sirolimus-Based Gvhd Prophylaxis.

Peripheral Hematopoietic Stem Cell Mobilization and Collection Efficacy Is Not an Independent Prognostic Factor for Autologous Stem Cell Transplantation.

Evaluating the Clinical Efficacy of Increased Granulocyte Colony-Stimulation Factor (GCSF) in Patients Who Fail a Standard Dose Regimen during Peripheral Blood Stem Cell Collection.

Feasibility and Efficacy of Mobilization of BCR/ABL- PBSC in CML Patients Receiving Imatinib.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only